Stay updated on Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check19 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check40 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.5%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
Stay in the know with updates to Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page.